Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Meneghini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|March 14, 2009
Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE studyL F Meneghini, A Dornhorst, S Sreenan, et al.
Diabetes, Obesity & Metabolism|June 26, 2012
Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy studyM Peyrot, A H Barnett, L F Meneghini, et al.
Diabetes Care|May 8, 1998
An electronic case manager for diabetes controlL F Meneghini, A M Albisser, R B Goldberg, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 9, 2012
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyM Peyrot, A H Barnett, L F Meneghini, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE studyL F Meneghini, K H Rosenberg, C Koenen, et al.
Mineral and Electrolyte Metabolism|January 1, 1993
Hypercalcemia in association with acute renal failure and rhabdomyolysis. Case report and literature reviewL F Meneghini, J R Oster, J R Camacho, et al.
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
The Journal of Clinical Endocrinology and Metabolism|September 9, 2011
Weight beneficial treatments for type 2 diabetesL F Meneghini, D Orozco-Beltran, K Khunti, et al.
Cardiovascular Drugs and Therapy|April 25, 2012
Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assayP Ferroni, D Della-Morte, A Pileggi, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|March 14, 2009
Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE studyL F Meneghini, A Dornhorst, S Sreenan, et al.
Diabetes, Obesity & Metabolism|June 26, 2012
Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy studyM Peyrot, A H Barnett, L F Meneghini, et al.
Diabetes Care|May 8, 1998
An electronic case manager for diabetes controlL F Meneghini, A M Albisser, R B Goldberg, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 9, 2012
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyM Peyrot, A H Barnett, L F Meneghini, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE studyL F Meneghini, K H Rosenberg, C Koenen, et al.
Mineral and Electrolyte Metabolism|January 1, 1993
Hypercalcemia in association with acute renal failure and rhabdomyolysis. Case report and literature reviewL F Meneghini, J R Oster, J R Camacho, et al.
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
The Journal of Clinical Endocrinology and Metabolism|September 9, 2011
Weight beneficial treatments for type 2 diabetesL F Meneghini, D Orozco-Beltran, K Khunti, et al.
Cardiovascular Drugs and Therapy|April 25, 2012
Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assayP Ferroni, D Della-Morte, A Pileggi, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.
Pageof 1